股本结构
单位:万股
公告日期 | 2024-02-28 | 2024-02-28 | 2023-11-09 | 2023-11-09 | 2023-08-08 | 2023-08-08 |
---|---|---|---|---|---|---|
证券总股本 | 13995.31 | 13950.58 | 11879.02 | 11873.04 | 9440.42 | 9430.84 |
普通股本 | 13995.31 | 13950.58 | 11879.02 | 11873.04 | 9440.42 | 9430.84 |
优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
变动日期 | 2024-02-23 | 2023-12-31 | 2023-10-31 | 2023-09-30 | 2023-07-31 | 2023-06-30 |
注释:中概股证券总股本=普通股股本/
存托凭证比例
历史变动
公告日期 | 变动后普通股本(万股) | 变动后优先股(万股) | 变动原因 | 变动日期 |
---|---|---|---|---|
2024-02-28 | 13995.31 | 未披露 | 定期报告 | 2024-02-23 |
2024-02-28 | 13950.58 | 未披露 |
更多>>
From December 31, 2022 to December 31, 2023
Issuance of common stock, net of issuance costs of $6,171
Stock issued under incentive programs
|
2023-12-31 |
2023-11-09 | 11879.02 | 未披露 | 定期报告 | 2023-10-31 |
2023-11-09 | 11873.04 | 未披露 |
更多>>
From June 30, 2023 to September 30, 2023
Stock issued under incentive programs
Issuance of common stock, net of issuance costs $3,063
|
2023-09-30 |
2023-08-08 | 9440.42 | 未披露 | 定期报告 | 2023-07-31 |
2023-08-08 | 9430.84 | 未披露 |
更多>>
From March 31, 2023 to June 30, 2023
Stock issued under incentive programs
Issuance of common stock, net of issuance costs $861
|
2023-06-30 |
2023-05-09 | 8630.51 | 未披露 | 定期报告 | 2023-04-30 |
2023-04-28 | 8630.44 | 未披露 | 定期报告 | 2023-04-18 |
2023-05-09 | 8629.15 | 未披露 |
更多>>
From December 31, 2022 to March 31, 2023
Stock issued under incentive programs
|
2023-03-31 |
2023-02-28 | 8617.32 | 未披露 | 定期报告 | 2023-02-21 |
2023-02-28 | 8603.99 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Stock issued under incentive programs
Issuance of common stock, net of issuance costs of $7,216
|
2022-12-31 |
2022-12-19 | 8597.90 | 未披露 |
更多>>
Common stock offered 6,500,000 shares by the company
|
2022-12-20 |
2022-12-19 | 7947.90 | 未披露 |
更多>>
In connection with the Common Stock Offering, the Company granted the Underwriters a 30-day option to purchase up to an additional 975,000 shares of Common Stock at the public offering price, less underwriting discounts and commissions, which was exercised in full by the Underwriters on December 16, 2022.
|
2022-12-16 |
2022-11-09 | 7850.40 | 未披露 | 定期报告 | 2022-10-31 |
2022-11-09 | 7847.68 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Stock issued under incentive programs
|
2022-09-30 |
2022-08-09 | 7821.51 | 未披露 | 定期报告 | 2022-07-31 |
2022-08-09 | 7816.69 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Stock issued under incentive programs
|
2022-06-30 |
2022-05-10 | 7813.46 | 未披露 | 定期报告 | 2022-04-30 |
2022-05-02 | 7812.95 | 未披露 | 定期报告 | 2022-04-19 |
2022-05-10 | 7812.30 | 未披露 |
更多>>
From December 31, 2021 to March 31, 2022
Stock issued under incentive programs
Issuance of common stock, net of issuance costs of $2311
|
2022-03-31 |
2022-03-01 | 7628.30 | 未披露 | 定期报告 | 2022-02-21 |
2022-03-01 | 7584.12 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Stock issued under incentive programs
Issuance of common stock, net of issuance costs of $7,292,000
|
2021-12-31 |
2021-11-05 | 7560.81 | 未披露 | 定期报告 | 2021-10-31 |
2021-11-05 | 7541.58 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Stock issued under incentive programs
|
2021-09-30 |
2021-08-05 | 7448.42 | 未披露 | 定期报告 | 2021-07-31 |
2021-08-05 | 7424.83 | 未披露 |
更多>>
From March 31, 2021 To June 30, 2021
Stock issued under incentive programs
|
2021-06-30 |
2021-05-10 | 7409.44 | 未披露 | 定期报告 | 2021-04-30 |
2021-04-30 | 7409.13 | 未披露 | 定期报告 | 2021-04-27 |
2021-05-03 | 7408.00 | 未披露 | 定期报告 | 2021-04-19 |
2021-05-10 | 7447.06 | 未披露 |
更多>>
From December 31, 2020 To March 31, 2021
Stock issued under incentive programs
Issuance of common stock, net of issuance costs of $7,292
|
2021-03-31 |
2021-03-01 | 7385.89 | 未披露 | 定期报告 | 2021-02-24 |
2021-03-01 | 7095.37 | 未披露 |
更多>>
From December 31, 2019 to December 31, 2020
Conversion of preferred stock
Stock issued under incentive programs
Issuance of common stock, net of issuance costs of $11,416
|
2020-12-31 |
2020-11-10 | 6366.00 | 未披露 | 定期报告 | 2020-10-31 |
2020-11-10 | 6292.75 | 43.89 |
更多>>
From June 30, 2020 to September 30, 2020
Stock issued under incentive programs
Issuance of common stock, net of issuance costs of $725
|
2020-09-30 |
2020-08-10 | 6127.81 | 未披露 | 定期报告 | 2020-07-31 |
2020-08-10 | 6121.12 | 43.89 |
更多>>
From March 31, 2020 to June 30, 2020
Exercise of stock options/Vesting of RSUs/Purchases under ESPP
Issuance of common stock, net of issuance costs of $2,647
|
2020-06-30 |
2020-05-13 | 5795.86 | 未披露 | 定期报告 | 2020-04-29 |
2020-04-29 | 5794.26 | 未披露 | 定期报告 | 2020-04-17 |
2020-05-11 | 5385.49 | 未披露 |
更多>>
From December 31, 2019 to March 31, 2020
Vesting of RSUs/Purchases under ESPP
Issuance of common stock, net of issuance costs of $2,498
|
2020-03-31 |
2020-03-11 | 5152.88 | 未披露 | 定期报告 | 2020-03-06 |
2020-03-11 | 3235.24 | 未披露 |
更多>>
from December 31, 2018 to December 31, 2019
Exercise of stock options/Vesting of RSUs/Purchases under ESPP
Issuance of common stock, net of issuance costs of $1,655
Fractional shares purchased in stock split
|
2019-12-31 |
2019-12-31 | 3212.26 | 未披露 | 定期报告 | 2019-12-26 |
2019-11-07 | 2657.74 | 未披露 | 定期报告 | 2019-10-31 |
2019-11-07 | 2552.86 | 未披露 |
更多>>
from June 30, 2019 to September 30, 2019
Exercise of stock options/Vesting of RSUs/Purchases under ESPP
Issuance of common stock, net of issuance costs of $161
|
2019-09-30 |
2019-08-07 | 2392.23 | 未披露 | 定期报告 | 2019-07-31 |
2019-08-07 | 2347.26 | 未披露 |
更多>>
From March 31, 2019 to June 30, 2019
Fractional shares purchased in stock split
|
2019-06-30 |
2019-05-09 | 2347.27 | 未披露 |
更多>>
Novavax, Inc. (Nasdaq:NVAX) announced it will effect a one-for-twenty reverse stock split of its issued and outstanding common stock. Stockholders of Novavax approved an amendment to Novavax' Second Amended and Restated Certificate of Incorporation (the Amended Certificate) to effect the reverse stock split at a Special Meeting of Stockholders held on May 8, 2019. The reverse stock split is intended to give Novavax greater flexibility in considering and planning for future potential business needs and to increase the per share trading price of the Novavax' common stock to enable Novavax to satisfy the minimum price requirement for continued listing on the Nasdaq Global Select Market. Pursuant to the Amended Certificate, the reverse stock split will be effective at 12:01 a.m., Eastern Time, on May 10, 2019. Novavax expects that upon the opening of trading on May 10, 2019, its common stock will trade on the Nasdaq Global Select Market on a split-adjusted basis under the current trading symbol "NVAX" and the new CUSIP number 670002 401.
|
2019-05-10 |
2019-05-02 | 46945.39 | 未披露 |
更多>>
from December 31, 2018 to March 25, 2019
Exercise of stock options/Purchases under ESPP
Issuance of common stock, net of issuance costs of $1,115
|
2019-03-25 |
2019-03-18 | 44134.42 | 未披露 | 定期报告 | 2019-03-12 |
2019-03-18 | 38445.06 | 未披露 |
更多>>
from December 31, 2017 to December 31, 2018
Exercise of stock options/Purchases under ESPP
Restricted stock cancelled
Issuance of common stock, net of issuance costs of $4,265
|
2018-12-31 |
2018-11-07 | 38285.01 | 未披露 | 定期报告 | 2018-10-31 |
2018-11-07 | 38273.06 | 未披露 | 定期报告 | 2018-09-30 |
2018-08-08 | 38259.18 | 未披露 | 定期报告 | 2018-08-03 |
2018-08-08 | 38168.40 | 未披露 | 定期报告 | 2018-06-30 |
2018-05-09 | 38167.49 | 未披露 | 定期报告 | 2018-04-30 |
2018-04-30 | 38163.74 | 未披露 | 定期报告 | 2018-04-18 |
2018-05-09 | 34674.90 | 未披露 | 定期报告 | 2018-03-31 |
2018-03-14 | 34374.21 | 未披露 | 定期报告 | 2018-03-09 |
2018-03-14 | 32322.94 | 未披露 |
更多>>
from December 31, 2016 to December 21, 2017
Exercise of stock options/Purchases under ESPP
Issuance of common stock, net of issuance costs of $1,065
|
2017-12-21 |
2017-11-07 | 31361.62 | 未披露 | 定期报告 | 2017-10-31 |
2017-11-07 | 31018.06 | 未披露 | 定期报告 | 2017-09-30 |
2017-08-08 | 29418.33 | 未披露 | 定期报告 | 2017-07-31 |
2017-08-08 | 28991.90 | 未披露 | 定期报告 | 2017-06-30 |
2017-05-08 | 28261.39 | 未披露 | 定期报告 | 2017-03-31 |
2017-02-27 | 27194.70 | 未披露 | 定期报告 | 2017-02-23 |
2017-02-27 | 27124.60 | 未披露 |
更多>>
From December 31, 2015 to December 23, 2016
Exercise of stock options/Purchase under ESPP
Restricted stock issued as compensation
|
2016-12-23 |
2016-11-09 | 27124.60 | 未披露 | 定期报告 | 2016-10-31 |
2016-11-09 | 27123.85 | 未披露 | 定期报告 | 2016-09-30 |
2016-08-09 | 27118.77 | 未披露 | 定期报告 | 2016-07-31 |
2016-08-09 | 27087.95 | 未披露 | 定期报告 | 2016-06-30 |
2016-05-05 | 27078.29 | 未披露 | 定期报告 | 2016-04-30 |
2016-04-20 | 27077.87 | 未披露 | 定期报告 | 2016-04-13 |
2016-05-05 | 27077.10 | 未披露 | 定期报告 | 2016-03-31 |
2016-02-29 | 27030.54 | 未披露 | 定期报告 | 2016-02-24 |
2016-02-29 | 26997.12 | 未披露 |
更多>>
From December 31, 2014 to December 31, 2015
Exercise of stock options/Purchase under ESPP
Restricted stock issued as compensation
Issuance of common stock, net of issuance costs of $11,912
|
2015-12-31 |
2015-11-09 | 26985.84 | 未披露 | 定期报告 | 2015-10-31 |
2015-11-09 | 26981.91 | 未披露 | 定期报告 | 2015-09-30 |
2015-08-10 | 26964.05 | 未披露 | 定期报告 | 2015-07-31 |
2015-08-10 | 26864.00 | 未披露 | 定期报告 | 2015-06-30 |
2015-05-07 | 26802.99 | 未披露 | 定期报告 | 2015-04-30 |
2015-04-30 | 26796.72 | 未披露 | 定期报告 | 2015-04-20 |
2015-05-07 | 26792.65 | 未披露 | 定期报告 | 2015-03-31 |
2015-02-27 | 23937.98 | 未披露 | 定期报告 | 2015-02-23 |
2015-02-27 | 23883.19 | 未披露 |
更多>>
from December 31, 2013 to December 31, 2014
Exercise of stock options/Purchase under ESPP
Restricted stock issued as compensation
Issuance of common stock, net of issuance costs of $7,105
|
2014-12-31 |
2014-11-06 | 23847.80 | 未披露 | 定期报告 | 2014-10-31 |
2014-11-06 | 23845.85 | 未披露 | 定期报告 | 2014-09-30 |
2014-08-07 | 23841.26 | 未披露 | 定期报告 | 2014-07-31 |
2014-08-07 | 23812.01 | 未披露 | 定期报告 | 2014-06-30 |
2014-05-08 | 20927.57 | 未披露 | 定期报告 | 2014-04-30 |
2014-04-30 | 20925.78 | 未披露 | 定期报告 | 2014-04-16 |
2014-05-08 | 20925.59 | 未披露 | 定期报告 | 2014-03-31 |
2014-03-12 | 20905.68 | 未披露 | 定期报告 | 2014-03-06 |
2014-01-24 | 20867.31 | 未披露 | 定期报告 | 2014-01-23 |
2014-03-12 | 20865.53 | 未披露 |
更多>>
from December 31, 2012 to December 31, 2013
Exercise of stock options
Issuance of common stock, net of issuance costs of $6,067
|
2013-12-31 |
2013-11-12 | 20851.07 | 未披露 | 定期报告 | 2013-10-31 |
2013-11-12 | 20850.97 | 未披露 | 定期报告 | 2013-09-30 |
2013-08-08 | 15271.83 | 未披露 | 定期报告 | 2013-07-30 |
2013-08-08 | 15270.96 | 未披露 | 定期报告 | 2013-06-30 |
2013-05-09 | 15246.40 | 未披露 | 定期报告 | 2013-04-30 |
2013-04-30 | 15125.98 | 未披露 | 定期报告 | 2013-04-16 |
2013-05-09 | 15170.02 | 未披露 | 定期报告 | 2013-03-31 |
2013-03-12 | 14794.48 | 未披露 | 定期报告 | 2013-03-04 |
2013-03-12 | 14794.33 | 未披露 |
更多>>
from December 31, 2011 to December 31, 2012
Exercise of stock options
Issuance of common stock, net of issuance costs of $365
|
2012-12-31 |
2012-11-09 | 14794.14 | 未披露 | 定期报告 | 2012-10-31 |
2012-11-09 | 13554.82 | 未披露 | 定期报告 | 2012-09-30 |
2012-08-09 | 13367.59 | 未披露 | 定期报告 | 2012-07-31 |
2012-08-09 | 13215.22 | 未披露 | 定期报告 | 2012-06-30 |
2012-05-09 | 12215.07 | 未披露 | 定期报告 | 2012-04-30 |
2012-05-09 | 12211.33 | 未披露 | 定期报告 | 2012-03-31 |
2012-03-14 | 12157.12 | 未披露 | 定期报告 | 2012-03-08 |
2012-03-14 | 11702.54 | 未披露 |
更多>>
from December 31, 2010 to December 31, 2011
Exercise of stock options
Restricted stock issued as compensation
Cancellation of common stock issued to former directors
Issuance of common stock under ATM, net of issuance costs of $246
|
2011-12-31 |
2011-11-08 | 11497.18 | 未披露 | 定期报告 | 2011-10-31 |
2011-11-08 | 11493.23 | 未披露 | 定期报告 | 2011-09-30 |
2011-08-09 | 11512.11 | 未披露 | 定期报告 | 2011-07-31 |
2011-08-09 | 11466.97 | 未披露 | 定期报告 | 2011-06-30 |
2011-05-10 | 11210.03 | 未披露 | 定期报告 | 2011-04-30 |
2011-03-28 | 11157.03 | 未披露 | 定期报告 | 2011-03-22 |
2011-03-28 | 11103.66 | 未披露 |
更多>>
from dec 31 2009 to dec 31 2010
Exercise of stock options
Restricted stock issued as compensation
Restricted stock cancelled
Issuance of common stock under ATM, net of issuance costs of $468
|
2010-12-31 |
2010-11-08 | 11110.14 | 未披露 | 定期报告 | 2010-10-31 |
2010-11-08 | 11064.47 | 未披露 | 定期报告 | 2010-09-30 |
2010-08-06 | 10735.79 | 未披露 | 定期报告 | 2010-07-31 |
2010-08-06 | 10184.68 | 未披露 | 定期报告 | 2010-06-30 |
2010-05-10 | 10048.85 | 未披露 | 定期报告 | 2010-04-30 |
2010-05-10 | 10028.65 | 未披露 | 定期报告 | 2010-03-31 |
2010-03-16 | 10027.80 | 未披露 | 定期报告 | 2010-03-11 |
2010-03-16 | 10026.25 | 未披露 |
更多>>
from December 31, 2008 to December 31, 2009
Exercise of stock options
Restricted stock issued as compensation
Issuance of common stock to Cadila, net of issuance costs of $406
Issuance of common stock to Rovi, net of issuance costs of $23
Conversion of convertible debt
Issuance of common stock under ATM, net of issuance costs of $682
Issuance of common stock, net of issuance costs of $1,631
|
2009-12-31 |
2009-03-31 | 6885.51 | 未披露 | 定期报告 | 2009-03-23 |
2009-03-31 | 6876.46 | 未披露 |
更多>>
from December 31, 2007 to December 31, 2008
Exercise of stock options
Issuance of common stock, net of issuance costs of $420
|
2008-12-31 |
2008-03-17 | 6196.21 | 未披露 | 定期报告 | 2008-03-17 |
2008-03-17 | 6194.99 | 未披露 |
更多>>
from December 31, 2006 to December 31, 2007
Exercise of stock options
Restricted stock issued as compensation
|
2007-12-31 |
2007-03-16 | 6184.51 | 未披露 | 定期报告 | 2007-02-28 |
2007-03-16 | 6179.11 | 未披露 |
更多>>
from December 31, 2005 to December 31, 2006
Exercise of stock options
Conversion of convertible debt
Restricted stock issued as compensation
Sales of common stock
|
2006-12-31 |
2006-03-06 | 5473.43 | 未披露 | 定期报告 | 2006-02-28 |
2006-03-06 | 5000.56 | 未披露 |
更多>>
from December 31, 2004 to December 31, 2005
Exercise of stock options
Issuance of common stock for prior services
Restricted stock issued as compensation
Conversion of convertible debt
Sales of common stock
|
2005-12-31 |
2005-03-15 | 3980.44 | 未披露 | 定期报告 | 2005-02-28 |
2005-03-15 | 3955.39 | 未披露 |
更多>>
from December 31, 2003 to December 31, 2004
Exercise of stock options
Shares issued for King Transaction
Sale of common stock
|
2004-12-31 |
2004-03-15 | 3471.91 | 未披露 | 定期报告 | 2004-02-27 |
2004-03-15 | 3471.83 | 未披露 |
更多>>
from December 31, 2002 to December 31, 2003
Exercise of stock options
Shares retired
Sales of common stock
Shares issued to King and other non-cash expense
|
2003-12-31 |
2003-03-28 | 2972.21 | 未披露 | 定期报告 | 2003-03-14 |
2003-03-28 | 2497.21 | 未披露 |
更多>>
from December 31, 2001 to December 31, 2002
Exercise of stock options and warrants
Shares issued to Fielding shareholders
Shares issued to King
Shares issued to 401K plan
|
2002-12-31 |
2002-03-15 | 2391.53 | 未披露 | 定期报告 | 2002-03-08 |
2002-03-15 | 2329.46 | 未披露 |
更多>>
from December 31, 2000 to December 31, 2001
Exercise of stock options and warrants
|
2001-12-31 |
2001-03-29 | 2224.75 | 未披露 | 定期报告 | 2001-03-16 |
2001-03-29 | 2210.41 | 未披露 |
更多>>
from December 31, 1999 to December 31, 2000
Private sale of common stock, net
Stock issued for acquisition
Exercise of stock options and warrants
|
2000-12-31 |
2001-03-29 | 2224.75 | 未披露 | 定期报告 | 2000-10-31 |
2000-03-09 | 1810.07 | 未披露 | 定期报告 | 2000-03-03 |
2000-03-09 | 1516.72 | 未披露 |
更多>>
from December 31, 1998 to December 31, 1999
Private sale of common stock
Offering costs
Exercise of stock options
|
1999-12-31 |
1999-04-15 | 1325.31 | 未披露 | 定期报告 | 1999-03-31 |
1999-04-15 | 1325.31 | 未披露 |
更多>>
from DECEMBER 31, 1997 to DECEMBER 31, 1998
Company contribution to employee 401(k) plan
Conversion of preferred stock
Dividend on preferred stock
Exercise of stock options
|
1998-12-31 |
1998-03-31 | 1206.04 | 未披露 | 定期报告 | 1998-03-20 |
1998-03-31 | 1201.20 | 未披露 |
更多>>
from December 31, 1996 to December 31, 1997
Company contribution to Employee 401k plan
Private sale of common stock, net
Exercise of stock options
|
1997-12-31 |
1997-03-21 | 1188.82 | 未披露 | 定期报告 | 1997-03-20 |
1997-03-21 | 1066.07 | 未披露 |
更多>>
from December 31,1995 to December 31,1996
Private sale of common stock,net
Exercise of stock options
|
1996-12-31 |
From December 31, 2022 to December 31, 2023
Issuance of common stock, net of issuance costs of $6,171
Stock issued under incentive programs
From June 30, 2023 to September 30, 2023
Stock issued under incentive programs
Issuance of common stock, net of issuance costs $3,063
From March 31, 2023 to June 30, 2023
Stock issued under incentive programs
Issuance of common stock, net of issuance costs $861
From December 31, 2022 to March 31, 2023
Stock issued under incentive programs
From December 31, 2021 to December 31, 2022
Stock issued under incentive programs
Issuance of common stock, net of issuance costs of $7,216
Common stock offered 6,500,000 shares by the company
In connection with the Common Stock Offering, the Company granted the Underwriters a 30-day option to purchase up to an additional 975,000 shares of Common Stock at the public offering price, less underwriting discounts and commissions, which was exercised in full by the Underwriters on December 16, 2022.
From June 30, 2022 to September 30, 2022
Stock issued under incentive programs
From March 31, 2022 to June 30, 2022
Stock issued under incentive programs
From December 31, 2021 to March 31, 2022
Stock issued under incentive programs
Issuance of common stock, net of issuance costs of $2311
From December 31, 2020 to December 31, 2021
Stock issued under incentive programs
Issuance of common stock, net of issuance costs of $7,292,000
From June 30, 2021 to September 30, 2021
Stock issued under incentive programs
From March 31, 2021 To June 30, 2021
Stock issued under incentive programs
From December 31, 2020 To March 31, 2021
Stock issued under incentive programs
Issuance of common stock, net of issuance costs of $7,292
From December 31, 2019 to December 31, 2020
Conversion of preferred stock
Stock issued under incentive programs
Issuance of common stock, net of issuance costs of $11,416
From June 30, 2020 to September 30, 2020
Stock issued under incentive programs
Issuance of common stock, net of issuance costs of $725
From March 31, 2020 to June 30, 2020
Exercise of stock options/Vesting of RSUs/Purchases under ESPP
Issuance of common stock, net of issuance costs of $2,647
From December 31, 2019 to March 31, 2020
Vesting of RSUs/Purchases under ESPP
Issuance of common stock, net of issuance costs of $2,498
from December 31, 2018 to December 31, 2019
Exercise of stock options/Vesting of RSUs/Purchases under ESPP
Issuance of common stock, net of issuance costs of $1,655
Fractional shares purchased in stock split
from June 30, 2019 to September 30, 2019
Exercise of stock options/Vesting of RSUs/Purchases under ESPP
Issuance of common stock, net of issuance costs of $161
From March 31, 2019 to June 30, 2019
Fractional shares purchased in stock split
Novavax, Inc. (Nasdaq:NVAX) announced it will effect a one-for-twenty reverse stock split of its issued and outstanding common stock. Stockholders of Novavax approved an amendment to Novavax' Second Amended and Restated Certificate of Incorporation (the Amended Certificate) to effect the reverse stock split at a Special Meeting of Stockholders held on May 8, 2019. The reverse stock split is intended to give Novavax greater flexibility in considering and planning for future potential business needs and to increase the per share trading price of the Novavax' common stock to enable Novavax to satisfy the minimum price requirement for continued listing on the Nasdaq Global Select Market. Pursuant to the Amended Certificate, the reverse stock split will be effective at 12:01 a.m., Eastern Time, on May 10, 2019. Novavax expects that upon the opening of trading on May 10, 2019, its common stock will trade on the Nasdaq Global Select Market on a split-adjusted basis under the current trading symbol "NVAX" and the new CUSIP number 670002 401.
from December 31, 2018 to March 25, 2019
Exercise of stock options/Purchases under ESPP
Issuance of common stock, net of issuance costs of $1,115
from December 31, 2017 to December 31, 2018
Exercise of stock options/Purchases under ESPP
Restricted stock cancelled
Issuance of common stock, net of issuance costs of $4,265
from December 31, 2016 to December 21, 2017
Exercise of stock options/Purchases under ESPP
Issuance of common stock, net of issuance costs of $1,065
From December 31, 2015 to December 23, 2016
Exercise of stock options/Purchase under ESPP
Restricted stock issued as compensation
From December 31, 2014 to December 31, 2015
Exercise of stock options/Purchase under ESPP
Restricted stock issued as compensation
Issuance of common stock, net of issuance costs of $11,912
from December 31, 2013 to December 31, 2014
Exercise of stock options/Purchase under ESPP
Restricted stock issued as compensation
Issuance of common stock, net of issuance costs of $7,105
from December 31, 2012 to December 31, 2013
Exercise of stock options
Issuance of common stock, net of issuance costs of $6,067
from December 31, 2011 to December 31, 2012
Exercise of stock options
Issuance of common stock, net of issuance costs of $365
from December 31, 2010 to December 31, 2011
Exercise of stock options
Restricted stock issued as compensation
Cancellation of common stock issued to former directors
Issuance of common stock under ATM, net of issuance costs of $246
from dec 31 2009 to dec 31 2010
Exercise of stock options
Restricted stock issued as compensation
Restricted stock cancelled
Issuance of common stock under ATM, net of issuance costs of $468
from December 31, 2008 to December 31, 2009
Exercise of stock options
Restricted stock issued as compensation
Issuance of common stock to Cadila, net of issuance costs of $406
Issuance of common stock to Rovi, net of issuance costs of $23
Conversion of convertible debt
Issuance of common stock under ATM, net of issuance costs of $682
Issuance of common stock, net of issuance costs of $1,631
from December 31, 2007 to December 31, 2008
Exercise of stock options
Issuance of common stock, net of issuance costs of $420
from December 31, 2006 to December 31, 2007
Exercise of stock options
Restricted stock issued as compensation
from December 31, 2005 to December 31, 2006
Exercise of stock options
Conversion of convertible debt
Restricted stock issued as compensation
Sales of common stock
from December 31, 2004 to December 31, 2005
Exercise of stock options
Issuance of common stock for prior services
Restricted stock issued as compensation
Conversion of convertible debt
Sales of common stock
from December 31, 2003 to December 31, 2004
Exercise of stock options
Shares issued for King Transaction
Sale of common stock
from December 31, 2002 to December 31, 2003
Exercise of stock options
Shares retired
Sales of common stock
Shares issued to King and other non-cash expense
from December 31, 2001 to December 31, 2002
Exercise of stock options and warrants
Shares issued to Fielding shareholders
Shares issued to King
Shares issued to 401K plan
from December 31, 2000 to December 31, 2001
Exercise of stock options and warrants
from December 31, 1999 to December 31, 2000
Private sale of common stock, net
Stock issued for acquisition
Exercise of stock options and warrants
from December 31, 1998 to December 31, 1999
Private sale of common stock
Offering costs
Exercise of stock options
from DECEMBER 31, 1997 to DECEMBER 31, 1998
Company contribution to employee 401(k) plan
Conversion of preferred stock
Dividend on preferred stock
Exercise of stock options
from December 31, 1996 to December 31, 1997
Company contribution to Employee 401k plan
Private sale of common stock, net
Exercise of stock options
from December 31,1995 to December 31,1996
Private sale of common stock,net
Exercise of stock options